Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease
- PMID: 8047373
Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease
Abstract
In eight patients with Legg-Perthes disease, we assessed the etiologic roles of thrombophilia caused by protein C and protein S deficiency and hypofibrinolysis mediated by low levels of tissue plasminogen activator activity. We speculated that thrombosis or hypofibrinolysis were common causes of Legg-Perthes disease. Three of the eight patients had protein C deficiency; they came from kindreds with previously undiagnosed protein C deficiency. In one of these three kindreds there were six protein C-deficient family members (beyond the proband child), four of whom had thrombotic events as adults. One of the eight patients had protein S deficiency, as did his brother who had sustained mesenteric vein thrombosis at age 43. One of the eight patients who had normal proteins C, S, and antithrombin III had hypofibrinolysis, failing to elevate tissue plasminogen activator activity after 10 min of venous occlusion at 100 mm Hg. Plasminogen activator inhibitor, alpha 2-antiplasmin, and fibrinogen values were normal in all eight patients. Beyond their Legg-Perthes disease, none of the eight patients had evidence for venous thrombosis. Of the eight patients, four had thrombophilia and one had hypofibrinolysis, disorders that we believe contributed to thrombotic venous occlusion of the femur with subsequent venous hypertension and bone death that characterize Legg-Perthes disease.
Similar articles
-
Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease.Clin Orthop Relat Res. 1998 Jul;(352):159-67. Clin Orthop Relat Res. 1998. PMID: 9678044
-
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease.J Pediatr Orthop. 1999 Jan-Feb;19(1):82-3. J Pediatr Orthop. 1999. PMID: 9890293
-
Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.J Bone Joint Surg Am. 1996 Jan;78(1):3-13. doi: 10.2106/00004623-199601000-00002. J Bone Joint Surg Am. 1996. PMID: 8550676
-
Laboratory screening of inherited thrombotic syndromes.Thromb Haemost. 1987 Jun 3;57(3):247-51. Thromb Haemost. 1987. PMID: 3116699 Review.
-
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].Orv Hetil. 2005 Oct 9;146(41):2121-5. Orv Hetil. 2005. PMID: 16304806 Review. Hungarian.
Cited by
-
The epidemiology and demographics of legg-calvé-perthes' disease.ISRN Orthop. 2011 Sep 5;2011:504393. doi: 10.5402/2011/504393. eCollection 2011. ISRN Orthop. 2011. PMID: 24977062 Free PMC article. Review.
-
The Effect of Vitamin D Deficiency as a Risk Factor of Early Fragmentation in Legg-Calve-Perthes Disease: A Prospective Study.Cureus. 2024 Mar 30;16(3):e57274. doi: 10.7759/cureus.57274. eCollection 2024 Mar. Cureus. 2024. PMID: 38686237 Free PMC article.
-
Legg-Calvé-Perthes disease and the risk of ADHD, depression, and mortality.Acta Orthop. 2014 Sep;85(5):501-5. doi: 10.3109/17453674.2014.939015. Epub 2014 Jul 18. Acta Orthop. 2014. PMID: 25036717 Free PMC article.
-
Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.Rheumatol Int. 2010 Apr;30(6):719-23. doi: 10.1007/s00296-009-1269-9. Epub 2009 Dec 12. Rheumatol Int. 2010. PMID: 20012628 Review.
-
Can large doses of glucocorticoids lead to Perthes? a case report and review of the literature.BMC Pediatr. 2021 Aug 12;21(1):339. doi: 10.1186/s12887-021-02755-4. BMC Pediatr. 2021. PMID: 34384372 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases